Author:
Surasi Krishna,Cummings Kristin J.,Hanson Carl,Morris Mary Kate,Salas Maria,Seftel David,Ortiz Liza,Thilakaratne Ruwan,Stainken Cameron,Wadford Debra A.
Publisher
Centers for Disease Control and Prevention (CDC)
Subject
Infectious Diseases,Microbiology (medical),Epidemiology
Reference16 articles.
1. Food and Drug Administration. BinaxNOW COVID-19 Ag card (PN 195–000)—instructions for use. 2020 Dec [cited 2021 Mar 15]. https://www.fda.gov/media/141570/download
2. Centers for Disease Control and Prevention. Interim guidance for antigen testing for SARS-CoV-2. 2020 Dec 5 [cited 2021 Mar 15]. https://www.cdc.gov/coronavirus/2019-ncov/lab/resources/antigen-tests-guidelines.html
3. Performance of the BinaxNOW COVID-19 antigen card test relative to the SARS-CoV-2 real-time reverse transcriptase polymerase chain reaction assay among symptomatic and asymptomatic healthcare employees.;James;Infect Control Hosp Epidemiol,2021
4. Performance characteristics of BinaxNOW COVID-19 antigen card for screening asymptomatic individuals in a university setting.;Okoye;J Clin Microbiol,2021
5. Performance characteristics of a rapid severe acute respiratory syndrome coronavirus 2 antigen detection assay at a public plaza testing site in San Francisco.;Pilarowski;J Infect Dis,2021
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献